Journey Medical (NASDAQ:DERM) Receives New Coverage from Analysts at Lake Street Capital
Lake Street Capital began coverage on shares of Journey Medical (NASDAQ:DERM – Free Report) in a report issued on Friday, Benzinga reports. The firm issued a buy rating and a $9.00 price target on the stock. A number of other research analysts have also recently commented on DERM. Roth Mkm initiated coverage on Journey Medical […]
More Stories
Chinese Stocks To Add to Your Watchlist – August 10th
Duolingo, Wynn Resorts, and Mettler-Toledo International are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool....
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by...
Fitness Stocks To Add to Your Watchlist – August 11th
Apple, Celsius, PDD, lululemon athletica, and Paychex are the five Fitness stocks to watch today, according to MarketBeat’s stock screener...
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System trimmed its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 12.4% in the...
Deutsche Bank AG Cuts Stock Position in Sprouts Farmers Market, Inc. (NASDAQ:SFM)
Deutsche Bank AG trimmed its holdings in Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) by 24.3% during the 1st...
Atria Wealth Solutions Inc. Sells 27,269 Shares of Paramount Global (NASDAQ:PARA)
Atria Wealth Solutions Inc. lessened its holdings in Paramount Global (NASDAQ:PARA – Free Report) by 33.2% during the 1st quarter,...